share_log

Piper Sandler Initiates Coverage On Unicycive Therapeutics With Overweight Rating, Announces Price Target of $9

Moomoo 24/7 ·  Apr 4 07:03

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Unicycive Therapeutics (NASDAQ:UNCY) with a Overweight rating and announces Price Target of $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment